[慢性咳临床研究的年度进展 (2024) ]
1The First Affiliated Hospital of Guangzhou Medical University, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou 510120, China.
概括
本综述涵盖了关于慢性咳的最新研究,这是一种影响日常生活的常见呼吸道问题. 它详细介绍了持续咳的流行病学,原因,诊断和管理.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 临床研究 临床研究
背景情况:
- 慢性咳是一种普遍的疾病,在初级保健和专业呼吸道诊所中都会遇到.
- 持续咳显著影响患者的生活质量,工作和学术追求.
- 了解慢性咳的病原和有效治疗是越来越多的研究兴趣领域.
研究的目的:
- 提供关于慢性咳的当前文献的全面审查.
- 总结一下慢性咳的流行病学,发病机制,评估和治疗方面的最新进展.
- 为该领域的临床医生和研究人员巩固知识.
主要方法:
- 对2023年10月1日至2024年9月30日期间发表的研究进行系统文献综述.
- 对研究的分析,重点是流行病学,病因因素,诊断方法和慢性咳的治疗策略.
- 综合了来自国家和国际研究计划的研究结果.
主要成果:
- 最近的研究强调了对慢性咳背后复杂机制的不断发展的见解.
- 更新的流行病学数据表明,慢性咳在不同患者群体的广泛影响.
- 新的诊断工具和治疗模式正在出现,提供了改进的管理选择.
结论:
- 慢性咳仍然是一个重大的临床挑战,需要采用多学科方法.
- 对其病原发生的持续研究对于开发有针对性和有效的疗法至关重要.
- 本综述综合了目前的证据,以指导临床实践和未来的研究方向.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
COPD: Pathogenesis and Clinical Features
228
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
228
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
224
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
224


